Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system

In this study, the CRISPR/Cas9 technology was used to establish murine tumor cell lines, devoid of MHC I or MHC II surface expression, respectively. The melanoma cell line B16F10 and the murine breast cancer cell line EO-771, the latter stably expressing the tumor antigen NY-BR-1 (EO-NY), were trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Krishna, Eisel, David, Lenkl, Clarissa, Goyal, Ashish, Diederichs, Sven, Dickes, Elke, Osen, Wolfram, Eichmüller, Stefan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354463/
https://www.ncbi.nlm.nih.gov/pubmed/28301575
http://dx.doi.org/10.1371/journal.pone.0174077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354463/
https://www.ncbi.nlm.nih.gov/pubmed/28301575
http://dx.doi.org/10.1371/journal.pone.0174077

Ejemplares similares